Evolving portal hypertension through Baveno VII recommendations.
Ann Hepatol
; 29(1): 101180, 2024.
Article
en En
| MEDLINE
| ID: mdl-37984701
ABSTRACT
The Baveno VII consensus workshop has provided several novel recommendations regarding the management of patients with clinically significant portal hypertension (CSPH). The expert panel summarized the existing data into simple clinical rules to aid clinicians in their clinical practice. The use of non-invasive tests (NITs), especially liver stiffness measurement (LSM), have gain an important role in daily practice. The use of LSM alone or in combination with platelet count can be used to rule-in and rule-out compensated advanced chronic liver disease (cACLD) and CSPH. Further decompensation events were defined as a prognostic stage associated with an even higher mortality than that associated with first decompensation. Moreover, the term hepatic recompensation was introduced in Baveno VII consensus implying a partial or complete regression of the functional and structural changes of cirrhosis after the removal of the underlying etiology. This review will summarize the reader main aspects of Baveno VII consensus regarding the use of NITs in cACLD, analyze further decompensation events, and evaluate recent recommendations for prophylaxis and management of liver decompensation events.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Várices Esofágicas y Gástricas
/
Diagnóstico por Imagen de Elasticidad
/
Hipertensión Portal
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article